InsiderClue
Insiders · Profile

Johnson Wendy S.

Director at EXAGEN · Chief Development Officer at OnKure Therapeutics · Interim Chief Operating Office at Armata Pharmaceuticals. Filing since 5 Oct 2015. CIK 0001652822

XGN EXAGEN INC. Director · 1 trade OKUR OnKure Therapeutics, Inc. Chief Development Officer · 1 trade ARMP Armata Pharmaceuticals, Inc. Interim Chief Operating Office · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
XGN EXAGEN INC.
3 Sep 2021
Director
Bought
1,000
$14.02K
opened
OKUR OnKure Therapeutics, Inc.
14 Jul 2021
Chief Development Officer
Sold, plan not stated
111,736
$949.76K
100%
ARMP Armata Pharmaceuticals, Inc.
5 Oct 2015
Interim Chief Operating Office
Bought
1,000
$4.43K
opened
3 decisions on file.